APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prenatal Second-Generation DNA Sequencing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Prenatal Second-Generation DNA Sequencing Market Analysis and Forecast 2026-2032

12 April 2026207 pages

Choose your research edition.

Industry ResearchPrenatal Second-Generation DNA Sequencing Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Prenatal Second-Generation DNA Sequencing Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Prenatal Second-Generation DNA Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prenatal Second-Generation DNA Sequencing Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Prenatal Second-Generation DNA Sequencing Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Prenatal Second-Generation DNA Sequencing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Prenatal Second-Generation DNA Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Prenatal Second-Generation DNA Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Prenatal Second-Generation DNA Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Prenatal Second-Generation DNA Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Prenatal Second-Generation DNA Sequencing include Natera, Labcorp, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB and Myriad Genetics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Prenatal Second-Generation DNA Sequencing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Prenatal Second-Generation DNA Sequencing, also provides the revenue of main regions and countries. Of the upcoming market potential for Prenatal Second-Generation DNA Sequencing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prenatal Second-Generation DNA Sequencing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Prenatal Second-Generation DNA Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Prenatal Second-Generation DNA Sequencing revenue, projected growth trends, production technology, application and end-user industry.

Prenatal Second-Generation DNA Sequencing Segment by Company

Natera

Labcorp

Quest Diagnostics

MedGenome

Mayo Clinic Laboratories

GeneDx

PreventionGenetics

SYNLAB

Myriad Genetics

GGA

Fulgent Genetics

Rainbow Genomics

BillionToOne

BGI Genomics

Berry Genomics

Annaroad

Weihansi Biomedical Technology

Prenatal Second-Generation DNA Sequencing Segment by Type

Targeted Panels

Exome Sequencing

Others

Prenatal Second-Generation DNA Sequencing Segment by Application

Public Hospitals

Private Hospitals

Prenatal Second-Generation DNA Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prenatal Second-Generation DNA Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prenatal Second-Generation DNA Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prenatal Second-Generation DNA Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Prenatal Second-Generation DNA Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Prenatal Second-Generation DNA Sequencing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prenatal Second-Generation DNA Sequencing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Targeted Panels Major Player Table 3. Exome Sequencing Major Player Table 4. Others Major Player Table 5. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Public Hospitals Major Player Table 7. Private Hospitals Major Player Table 8. Prenatal Second-Generation DNA Sequencing Industry Trends Table 9. Prenatal Second-Generation DNA Sequencing Industry Drivers Table 10. Prenatal Second-Generation DNA Sequencing Industry Opportunities and Challenges Table 11. Prenatal Second-Generation DNA Sequencing Industry Restraints Table 12. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Prenatal Second-Generation DNA Sequencing Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Prenatal Second-Generation DNA Sequencing Market Share by Region (2021-2026) Table 15. Global Prenatal Second-Generation DNA Sequencing Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Prenatal Second-Generation DNA Sequencing Market Share by Region (2027-2032) Table 17. Global Prenatal Second-Generation DNA Sequencing Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Players (2021-2026) Table 19. Global Prenatal Second-Generation DNA Sequencing Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Prenatal Second-Generation DNA Sequencing Key Players Headquarters & Area Served Table 21. Global Prenatal Second-Generation DNA Sequencing Players, Product Type & Application Table 22. Global Prenatal Second-Generation DNA Sequencing Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Prenatal Second-Generation DNA Sequencing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Prenatal Second-Generation DNA Sequencing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Prenatal Second-Generation DNA Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Prenatal Second-Generation DNA Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Type (2021-2026) Table 29. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Type (2027-2032) Table 30. Global Prenatal Second-Generation DNA Sequencing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Prenatal Second-Generation DNA Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Prenatal Second-Generation DNA Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Application (2021-2026) Table 34. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Application (2027-2032) Table 35. Natera Company Information Table 36. Natera Business Overview Table 37. Natera Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Natera Prenatal Second-Generation DNA Sequencing Product Portfolio Table 39. Natera Recent Development Table 40. Labcorp Company Information Table 41. Labcorp Business Overview Table 42. Labcorp Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Labcorp Prenatal Second-Generation DNA Sequencing Product Portfolio Table 44. Labcorp Recent Development Table 45. Quest Diagnostics Company Information Table 46. Quest Diagnostics Business Overview Table 47. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 49. Quest Diagnostics Recent Development Table 50. MedGenome Company Information Table 51. MedGenome Business Overview Table 52. MedGenome Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. MedGenome Prenatal Second-Generation DNA Sequencing Product Portfolio Table 54. MedGenome Recent Development Table 55. Mayo Clinic Laboratories Company Information Table 56. Mayo Clinic Laboratories Business Overview Table 57. Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Product Portfolio Table 59. Mayo Clinic Laboratories Recent Development Table 60. GeneDx Company Information Table 61. GeneDx Business Overview Table 62. GeneDx Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. GeneDx Prenatal Second-Generation DNA Sequencing Product Portfolio Table 64. GeneDx Recent Development Table 65. PreventionGenetics Company Information Table 66. PreventionGenetics Business Overview Table 67. PreventionGenetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. PreventionGenetics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 69. PreventionGenetics Recent Development Table 70. SYNLAB Company Information Table 71. SYNLAB Business Overview Table 72. SYNLAB Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. SYNLAB Prenatal Second-Generation DNA Sequencing Product Portfolio Table 74. SYNLAB Recent Development Table 75. Myriad Genetics Company Information Table 76. Myriad Genetics Business Overview Table 77. Myriad Genetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Myriad Genetics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 79. Myriad Genetics Recent Development Table 80. GGA Company Information Table 81. GGA Business Overview Table 82. GGA Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. GGA Prenatal Second-Generation DNA Sequencing Product Portfolio Table 84. GGA Recent Development Table 85. Fulgent Genetics Company Information Table 86. Fulgent Genetics Business Overview Table 87. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 89. Fulgent Genetics Recent Development Table 90. Rainbow Genomics Company Information Table 91. Rainbow Genomics Business Overview Table 92. Rainbow Genomics Prenatal Second-Generation DNA Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Rainbow Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 94. Rainbow Genomics Recent Development Table 95. BillionToOne Company Information Table 96. BillionToOne Business Overview Table 97. BillionToOne Prenatal Second-Generation DNA Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. BillionToOne Prenatal Second-Generation DNA Sequencing Product Portfolio Table 99. BillionToOne Recent Development Table 100. BGI Genomics Company Information Table 101. BGI Genomics Business Overview Table 102. BGI Genomics Prenatal Second-Generation DNA Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. BGI Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 104. BGI Genomics Recent Development Table 105. Berry Genomics Company Information Table 106. Berry Genomics Business Overview Table 107. Berry Genomics Prenatal Second-Generation DNA Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Berry Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 109. Berry Genomics Recent Development Table 110. Annaroad Company Information Table 111. Annaroad Business Overview Table 112. Annaroad Prenatal Second-Generation DNA Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Annaroad Prenatal Second-Generation DNA Sequencing Product Portfolio Table 114. Annaroad Recent Development Table 115. Weihansi Biomedical Technology Company Information Table 116. Weihansi Biomedical Technology Business Overview Table 117. Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Product Portfolio Table 119. Weihansi Biomedical Technology Recent Development Table 120. North America Prenatal Second-Generation DNA Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 121. North America Prenatal Second-Generation DNA Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 122. North America Prenatal Second-Generation DNA Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 123. North America Prenatal Second-Generation DNA Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 124. North America Prenatal Second-Generation DNA Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Prenatal Second-Generation DNA Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Prenatal Second-Generation DNA Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 127. Europe Prenatal Second-Generation DNA Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 128. Europe Prenatal Second-Generation DNA Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 129. Europe Prenatal Second-Generation DNA Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 130. Europe Prenatal Second-Generation DNA Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 131. Europe Prenatal Second-Generation DNA Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Prenatal Second-Generation DNA Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 133. Europe Prenatal Second-Generation DNA Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 134. China Prenatal Second-Generation DNA Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 135. China Prenatal Second-Generation DNA Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 136. China Prenatal Second-Generation DNA Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 137. China Prenatal Second-Generation DNA Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 138. Asia Prenatal Second-Generation DNA Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 139. Asia Prenatal Second-Generation DNA Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 140. Asia Prenatal Second-Generation DNA Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 141. Asia Prenatal Second-Generation DNA Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Prenatal Second-Generation DNA Sequencing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Asia Prenatal Second-Generation DNA Sequencing Revenue by Region (US$ Million) & (2021-2026) Table 144. Asia Prenatal Second-Generation DNA Sequencing Revenue by Region (US$ Million) & (2027-2032) Table 145. SAMEA Prenatal Second-Generation DNA Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 146. SAMEA Prenatal Second-Generation DNA Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 147. SAMEA Prenatal Second-Generation DNA Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 148. SAMEA Prenatal Second-Generation DNA Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 149. SAMEA Prenatal Second-Generation DNA Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. SAMEA Prenatal Second-Generation DNA Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 151. SAMEA Prenatal Second-Generation DNA Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Prenatal Second-Generation DNA Sequencing Image Figure 2. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prenatal Second-Generation DNA Sequencing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Targeted Panels Image Figure 5. Exome Sequencing Image Figure 6. Others Image Figure 7. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Prenatal Second-Generation DNA Sequencing Market Size Share 2021 VS 2025 VS 2032 Figure 9. Public Hospitals Image Figure 10. Private Hospitals Image Figure 11. Global Prenatal Second-Generation DNA Sequencing Market Size (US$ Million) & (2021-2032) Figure 12. Global Prenatal Second-Generation DNA Sequencing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Prenatal Second-Generation DNA Sequencing Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Prenatal Second-Generation DNA Sequencing Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Prenatal Second-Generation DNA Sequencing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Type (2021-2032) Figure 19. Global Prenatal Second-Generation DNA Sequencing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Application (2021-2032) Figure 22. North America Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Prenatal Second-Generation DNA Sequencing Revenue Share by Type (2021-2032) Figure 24. North America Prenatal Second-Generation DNA Sequencing Revenue Share by Application (2021-2032) Figure 25. North America Prenatal Second-Generation DNA Sequencing Revenue Share by Country (2021-2032) Figure 26. United States Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Prenatal Second-Generation DNA Sequencing Revenue Share by Type (2021-2032) Figure 31. Europe Prenatal Second-Generation DNA Sequencing Revenue Share by Application (2021-2032) Figure 32. Europe Prenatal Second-Generation DNA Sequencing Revenue Share by Country (2021-2032) Figure 33. Germany Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Prenatal Second-Generation DNA Sequencing Revenue Share by Type (2021-2032) Figure 43. China Prenatal Second-Generation DNA Sequencing Revenue Share by Application (2021-2032) Figure 44. Asia Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Prenatal Second-Generation DNA Sequencing Revenue Share by Type (2021-2032) Figure 46. Asia Prenatal Second-Generation DNA Sequencing Revenue Share by Application (2021-2032) Figure 47. Asia Prenatal Second-Generation DNA Sequencing Revenue Share by Region (2021-2032) Figure 48. Japan Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Prenatal Second-Generation DNA Sequencing Revenue Share by Type (2021-2032) Figure 56. SAMEA Prenatal Second-Generation DNA Sequencing Revenue Share by Application (2021-2032) Figure 57. SAMEA Prenatal Second-Generation DNA Sequencing Revenue Share by Country (2021-2032) Figure 58. Brazil Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Prenatal Second-Generation DNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Panels
  • Exome Sequencing
  • Others
Applications
  • Public Hospitals
  • Private Hospitals
Companies covered
  • Natera
  • Labcorp
  • Quest Diagnostics
  • MedGenome
  • Mayo Clinic Laboratories
  • GeneDx
  • PreventionGenetics
  • SYNLAB
  • Myriad Genetics
  • GGA
  • Fulgent Genetics
  • Rainbow Genomics
  • BillionToOne
  • BGI Genomics
  • Berry Genomics
  • Annaroad
  • Weihansi Biomedical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Prenatal Second-Generation DNA Sequencing Market by Type
  3. 1.2.1 Global Prenatal Second-Generation DNA Sequencing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Targeted Panels
  5. 1.2.3 Exome Sequencing
  6. 1.2.4 Others
  7. 1.3 Prenatal Second-Generation DNA Sequencing Market by Application
  8. 1.3.1 Global Prenatal Second-Generation DNA Sequencing Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Public Hospitals
  10. 1.3.3 Private Hospitals
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Prenatal Second-Generation DNA Sequencing Market Dynamics
  1. 2.1 Prenatal Second-Generation DNA Sequencing Industry Trends
  2. 2.2 Prenatal Second-Generation DNA Sequencing Industry Drivers
  3. 2.3 Prenatal Second-Generation DNA Sequencing Industry Opportunities and Challenges
  4. 2.4 Prenatal Second-Generation DNA Sequencing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Prenatal Second-Generation DNA Sequencing Market Perspective (2021-2032)
  2. 3.2 Global Prenatal Second-Generation DNA Sequencing Growth Trends by Region
  3. 3.2.1 Global Prenatal Second-Generation DNA Sequencing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Prenatal Second-Generation DNA Sequencing Market Size by Region (2021-2026)
  5. 3.2.3 Global Prenatal Second-Generation DNA Sequencing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Prenatal Second-Generation DNA Sequencing Revenue by Players
  2. 4.1.1 Global Prenatal Second-Generation DNA Sequencing Revenue by Players (2021-2026)
  3. 4.1.2 Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Prenatal Second-Generation DNA Sequencing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Prenatal Second-Generation DNA Sequencing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Prenatal Second-Generation DNA Sequencing Key Players Headquarters & Area Served
  7. 4.4 Global Prenatal Second-Generation DNA Sequencing Players, Product Type & Application
  8. 4.5 Global Prenatal Second-Generation DNA Sequencing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Prenatal Second-Generation DNA Sequencing Market CR5 and HHI
  11. 4.6.3 2025 Prenatal Second-Generation DNA Sequencing Tier 1, Tier 2, and Tier 3
5 Prenatal Second-Generation DNA Sequencing Market Size by Type
  1. 5.1 Global Prenatal Second-Generation DNA Sequencing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Prenatal Second-Generation DNA Sequencing Revenue by Type (2021-2032)
  3. 5.3 Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Type (2021-2032)
6 Prenatal Second-Generation DNA Sequencing Market Size by Application
  1. 6.1 Global Prenatal Second-Generation DNA Sequencing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Prenatal Second-Generation DNA Sequencing Revenue by Application (2021-2032)
  3. 6.3 Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Natera
  2. 7.1.1 Natera Company Information
  3. 7.1.2 Natera Business Overview
  4. 7.1.3 Natera Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Natera Prenatal Second-Generation DNA Sequencing Product Portfolio
  6. 7.1.5 Natera Recent Developments
  7. 7.2 Labcorp
  8. 7.2.1 Labcorp Company Information
  9. 7.2.2 Labcorp Business Overview
  10. 7.2.3 Labcorp Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Labcorp Prenatal Second-Generation DNA Sequencing Product Portfolio
  12. 7.2.5 Labcorp Recent Developments
  13. 7.3 Quest Diagnostics
  14. 7.3.1 Quest Diagnostics Company Information
  15. 7.3.2 Quest Diagnostics Business Overview
  16. 7.3.3 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product Portfolio
  18. 7.3.5 Quest Diagnostics Recent Developments
  19. 7.4 MedGenome
  20. 7.4.1 MedGenome Company Information
  21. 7.4.2 MedGenome Business Overview
  22. 7.4.3 MedGenome Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 MedGenome Prenatal Second-Generation DNA Sequencing Product Portfolio
  24. 7.4.5 MedGenome Recent Developments
  25. 7.5 Mayo Clinic Laboratories
  26. 7.5.1 Mayo Clinic Laboratories Company Information
  27. 7.5.2 Mayo Clinic Laboratories Business Overview
  28. 7.5.3 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Product Portfolio
  30. 7.5.5 Mayo Clinic Laboratories Recent Developments
  31. 7.6 GeneDx
  32. 7.6.1 GeneDx Company Information
  33. 7.6.2 GeneDx Business Overview
  34. 7.6.3 GeneDx Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 GeneDx Prenatal Second-Generation DNA Sequencing Product Portfolio
  36. 7.6.5 GeneDx Recent Developments
  37. 7.7 PreventionGenetics
  38. 7.7.1 PreventionGenetics Company Information
  39. 7.7.2 PreventionGenetics Business Overview
  40. 7.7.3 PreventionGenetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 PreventionGenetics Prenatal Second-Generation DNA Sequencing Product Portfolio
  42. 7.7.5 PreventionGenetics Recent Developments
  43. 7.8 SYNLAB
  44. 7.8.1 SYNLAB Company Information
  45. 7.8.2 SYNLAB Business Overview
  46. 7.8.3 SYNLAB Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 SYNLAB Prenatal Second-Generation DNA Sequencing Product Portfolio
  48. 7.8.5 SYNLAB Recent Developments
  49. 7.9 Myriad Genetics
  50. 7.9.1 Myriad Genetics Company Information
  51. 7.9.2 Myriad Genetics Business Overview
  52. 7.9.3 Myriad Genetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Myriad Genetics Prenatal Second-Generation DNA Sequencing Product Portfolio
  54. 7.9.5 Myriad Genetics Recent Developments
  55. 7.10 GGA
  56. 7.10.1 GGA Company Information
  57. 7.10.2 GGA Business Overview
  58. 7.10.3 GGA Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 GGA Prenatal Second-Generation DNA Sequencing Product Portfolio
  60. 7.10.5 GGA Recent Developments
  61. 7.11 Fulgent Genetics
  62. 7.11.1 Fulgent Genetics Company Information
  63. 7.11.2 Fulgent Genetics Business Overview
  64. 7.11.3 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product Portfolio
  66. 7.11.5 Fulgent Genetics Recent Developments
  67. 7.12 Rainbow Genomics
  68. 7.12.1 Rainbow Genomics Company Information
  69. 7.12.2 Rainbow Genomics Business Overview
  70. 7.12.3 Rainbow Genomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Rainbow Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio
  72. 7.12.5 Rainbow Genomics Recent Developments
  73. 7.13 BillionToOne
  74. 7.13.1 BillionToOne Company Information
  75. 7.13.2 BillionToOne Business Overview
  76. 7.13.3 BillionToOne Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 BillionToOne Prenatal Second-Generation DNA Sequencing Product Portfolio
  78. 7.13.5 BillionToOne Recent Developments
  79. 7.14 BGI Genomics
  80. 7.14.1 BGI Genomics Company Information
  81. 7.14.2 BGI Genomics Business Overview
  82. 7.14.3 BGI Genomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 BGI Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio
  84. 7.14.5 BGI Genomics Recent Developments
  85. 7.15 Berry Genomics
  86. 7.15.1 Berry Genomics Company Information
  87. 7.15.2 Berry Genomics Business Overview
  88. 7.15.3 Berry Genomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Berry Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio
  90. 7.15.5 Berry Genomics Recent Developments
  91. 7.16 Annaroad
  92. 7.16.1 Annaroad Company Information
  93. 7.16.2 Annaroad Business Overview
  94. 7.16.3 Annaroad Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Annaroad Prenatal Second-Generation DNA Sequencing Product Portfolio
  96. 7.16.5 Annaroad Recent Developments
  97. 7.17 Weihansi Biomedical Technology
  98. 7.17.1 Weihansi Biomedical Technology Company Information
  99. 7.17.2 Weihansi Biomedical Technology Business Overview
  100. 7.17.3 Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Product Portfolio
  102. 7.17.5 Weihansi Biomedical Technology Recent Developments
8 North America
  1. 8.1 North America Prenatal Second-Generation DNA Sequencing Revenue (2021-2032)
  2. 8.2 North America Prenatal Second-Generation DNA Sequencing Revenue by Type (2021-2032)
  3. 8.2.1 North America Prenatal Second-Generation DNA Sequencing Revenue by Type (2021-2026)
  4. 8.2.2 North America Prenatal Second-Generation DNA Sequencing Revenue by Type (2027-2032)
  5. 8.3 North America Prenatal Second-Generation DNA Sequencing Revenue Share by Type (2021-2032)
  6. 8.4 North America Prenatal Second-Generation DNA Sequencing Revenue by Application (2021-2032)
  7. 8.4.1 North America Prenatal Second-Generation DNA Sequencing Revenue by Application (2021-2026)
  8. 8.4.2 North America Prenatal Second-Generation DNA Sequencing Revenue by Application (2027-2032)
  9. 8.5 North America Prenatal Second-Generation DNA Sequencing Revenue Share by Application (2021-2032)
  10. 8.6 North America Prenatal Second-Generation DNA Sequencing Revenue by Country
  11. 8.6.1 North America Prenatal Second-Generation DNA Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Prenatal Second-Generation DNA Sequencing Revenue by Country (2021-2026)
  13. 8.6.3 North America Prenatal Second-Generation DNA Sequencing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Prenatal Second-Generation DNA Sequencing Revenue (2021-2032)
  2. 9.2 Europe Prenatal Second-Generation DNA Sequencing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Prenatal Second-Generation DNA Sequencing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Prenatal Second-Generation DNA Sequencing Revenue by Type (2027-2032)
  5. 9.3 Europe Prenatal Second-Generation DNA Sequencing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Prenatal Second-Generation DNA Sequencing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Prenatal Second-Generation DNA Sequencing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Prenatal Second-Generation DNA Sequencing Revenue by Application (2027-2032)
  9. 9.5 Europe Prenatal Second-Generation DNA Sequencing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Prenatal Second-Generation DNA Sequencing Revenue by Country
  11. 9.6.1 Europe Prenatal Second-Generation DNA Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Prenatal Second-Generation DNA Sequencing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Prenatal Second-Generation DNA Sequencing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Prenatal Second-Generation DNA Sequencing Revenue (2021-2032)
  2. 10.2 China Prenatal Second-Generation DNA Sequencing Revenue by Type (2021-2032)
  3. 10.2.1 China Prenatal Second-Generation DNA Sequencing Revenue by Type (2021-2026)
  4. 10.2.2 China Prenatal Second-Generation DNA Sequencing Revenue by Type (2027-2032)
  5. 10.3 China Prenatal Second-Generation DNA Sequencing Revenue Share by Type (2021-2032)
  6. 10.4 China Prenatal Second-Generation DNA Sequencing Revenue by Application (2021-2032)
  7. 10.4.1 China Prenatal Second-Generation DNA Sequencing Revenue by Application (2021-2026)
  8. 10.4.2 China Prenatal Second-Generation DNA Sequencing Revenue by Application (2027-2032)
  9. 10.5 China Prenatal Second-Generation DNA Sequencing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Prenatal Second-Generation DNA Sequencing Revenue (2021-2032)
  2. 11.2 Asia Prenatal Second-Generation DNA Sequencing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Prenatal Second-Generation DNA Sequencing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Prenatal Second-Generation DNA Sequencing Revenue by Type (2027-2032)
  5. 11.3 Asia Prenatal Second-Generation DNA Sequencing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Prenatal Second-Generation DNA Sequencing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Prenatal Second-Generation DNA Sequencing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Prenatal Second-Generation DNA Sequencing Revenue by Application (2027-2032)
  9. 11.5 Asia Prenatal Second-Generation DNA Sequencing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Prenatal Second-Generation DNA Sequencing Revenue by Country
  11. 11.6.1 Asia Prenatal Second-Generation DNA Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Prenatal Second-Generation DNA Sequencing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Prenatal Second-Generation DNA Sequencing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Prenatal Second-Generation DNA Sequencing Revenue (2021-2032)
  2. 12.2 SAMEA Prenatal Second-Generation DNA Sequencing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Prenatal Second-Generation DNA Sequencing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Prenatal Second-Generation DNA Sequencing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Prenatal Second-Generation DNA Sequencing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Prenatal Second-Generation DNA Sequencing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Prenatal Second-Generation DNA Sequencing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Prenatal Second-Generation DNA Sequencing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Prenatal Second-Generation DNA Sequencing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Prenatal Second-Generation DNA Sequencing Revenue by Country
  11. 12.6.1 SAMEA Prenatal Second-Generation DNA Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Prenatal Second-Generation DNA Sequencing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Prenatal Second-Generation DNA Sequencing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst